Avonex (interferon beta-1a) for multiple sclerosis

The FDA will soon approve Avonex (interferon beta-1a) for multiple sclerosis.

It's a beta-interferon...similar to Betaseron.

Both Avonex and Betaseron help reduce the frequency of relapses in patients with the relapsing-remitting form of MS. In addition, Avonex also slows the progression of the disease.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote